Expand ACAD Menu
ACAD MENU

ACAD Stock Posts


Unusual Option Volume

ACAD Acadia Pharmaceuticals21.33-0.27 (-1.3%)

Acadia Pharmaceuticals trades 3,220 contracts.
Upcoming Earnings

ACAD Acadia Pharmaceuticals22.74+0.39 (+1.7%)

Acadia Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±7.0% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±5.3%. View Expected Move (Conf Call: May 6 4:30 PM)
Upcoming Earnings

ACAD Acadia Pharmaceuticals24.64+0.05 (+0.2%)

Acadia Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±10.6% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±5.4%. View Expected Move (Conf Call: Feb 25 4:30 PM)
ACAD #AcadiaPharmaceuticals stock declines -4.3% in after hours trading. See the latest news.

After Hours Decliner

ACAD Acadia Pharmaceuticals26.13+1.00+4.0%

After Hours:25.01-1.12 (-4.3%)

Acadia Pharmaceuticals Provides Update on Regulatory Submission for Trofinetide for the Treatment of Rett Syndrome in the European Union

Business WireMon, 2-Feb 4:05 PM

ACAD #AcadiaPharmaceuticals stock declines -4.3% in after hours trading. See the latest news.

After Hours Decliner

ACAD Acadia Pharmaceuticals26.13+1.00+4.0%

After Hours:25.01-1.12 (-4.3%)

Acadia Pharmaceuticals Provides Update on Regulatory Submission for Trofinetide for the Treatment of Rett Syndrome in the European Union

Business WireMon, 2-Feb 4:05 PM

Unusual Option Volume

ACAD Acadia Pharmaceuticals24.50+0.60 (+2.5%)

Acadia Pharmaceuticals trades 2,679 contracts. The company has the following event: Citi's 2025 Global Healthcare Conference on Dec 2, 2025.
Market Data Delayed 15 Minutes